World’s largest Alzheimer’s survey reveals most adults believe a cure will be developed in their lifetime

18 September 2018 - A new survey released today by Banner Alzheimer’s Institute (BAI), Novartis, and Amgen, in association with Alzheimer’s Disease International, reveals that most adults believe a cure for Alzheimer’s will be found within their lifetime.

The survey, which includes 10,000 adults across 10 countries, aims to raise awareness about how volunteers can take part in clinical studies to benefit Alzheimer’s research during World Alzheimer’s Month.

Key findings of the survey include:

  • 91% believe of adults the solution to tackling diseases lies in medical research
  • 79% are willing to participate in Alzheimer’s research but three-quarters (75%) have no idea how to get involved
  • 62% are worried that they may develop Alzheimer’s disease

With these insights, we hope to raise awareness about how volunteers can take part in clinical studies to benefit Alzheimer’s research this World Alzheimer’s Month.

Paola Barbarino, Chief Executive Officer at ADI, said: “At present, there is no cure and limited treatment options for Alzheimer’s, but this survey clearly shows that people are willing to participate in research to help treat and to hopefully find a cure. We need to demystify and remove awareness barriers to participation in medical research, making all suitable candidates aware of how they can get involved.” 

Novartis, Amgen and BAI are sponsors of the Alzheimer’s Prevention Initiative’s Generation Program, which is evaluating investigational treatments to help prevent or delay the onset of Alzheimer’s. The Program is enrolling volunteers aged 60-75 who are at higher risk of developing Alzheimer’s but do not currently have or show signs of the disease.

For more information about the Generation Program, visit www.GenerationProgram.com or contact the ‘med info’ department at a nearby Novartis or Amgen office.

Where next?